Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v5-EN
Language French English
Date Updated 2020-09-30 2020-07-25
Drug Identification Number 02240255 02240255
Brand name ADACEL ADACEL
Common or Proper name Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed
Company Name SANOFI PASTEUR LIMITED SANOFI PASTEUR LIMITED
Ingredients FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID PERTACTIN DIPHTHERIA TOXOID TETANUS TOXOID FIMBRIAE TYPES 2 AND 3 FILAMENTOUS HAEMAGGLUTININ PERTUSSIS TOXOID PERTACTIN DIPHTHERIA TOXOID TETANUS TOXOID FIMBRIAE TYPES 2 AND 3
Strength(s) 5MCG 2.5MCG 3MCG 2LF 5LF 5MCG 5MCG 2.5MCG 3MCG 2LF 5LF 5MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 0.5 mL vial and 5 x 0.5 mL vials 1 x 0.5 mL vial and 5 x 0.5 mL vials
ATC code J07AJ J07AJ
ATC description BACTERIAL VACCINES BACTERIAL VACCINES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-07-24 2020-07-24
Actual start date 2020-07-24 2020-07-24
Estimated end date 2021-03-31 2021-03-31
Actual end date 2020-09-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Reason for Shortage: Due to delays in manufacturing and shipment of product for Canada | Allocation plan in place to meet public market demand; product not available for private market Reason for Shortage: Due to delays in manufacturing and shipment of product for Canada | Allocation plan in place to meet public market demand; product not available for private market
Health Canada comments